Merrimack Pharmaceuticals
MACK
#8699
Rank
โ‚น21.54 B
Marketcap
โ‚น1,457
Share price
0.00%
Change (1 day)
14.74%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2024 (TTM): โ‚น1,156

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,335. In 2016 the company made an earnings per share (EPS) of -โ‚น1,178 an increase over its 2015 EPS that were of -โ‚น1,271.

EPS history for Merrimack Pharmaceuticals from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)โ‚น1,156
2016-โ‚น1,178-7.35%
2015-โ‚น1,27165%
2014-โ‚น770.28-39.39%
2013-โ‚น1,271-54.01%
2012-โ‚น2,763

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น246.46-81.53%๐Ÿ‡ซ๐Ÿ‡ท France
Geron
GERN
-โ‚น12.52-100.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Clovis Oncology
CLVS
-โ‚น181.98-113.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น80.88-106.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,386-653.46%๐Ÿ‡บ๐Ÿ‡ธ USA